Treatment of Orelabrutinib+Hi-CVP Regimen for Previously Untreated MZL
Clinical trial NCT07480863 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07480863
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-01
- Primary completion
- 2029-10-01
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.